Ryan Lee, MD

Residency: ChristianaCare
Medical School: Thomas Jefferson University

Released in October 2019, CRASH-3 is the latest trial exploring the benefits of tranexamic acid, this time in traumatic brain injury. The bottom line: TXA hasn't been shown to reduce mortality.
CHAT NOW
CHAT OFFLINE